Access the full text.
Sign up today, get DeepDyve free for 14 days.
Hao Zheng, T. Dai, Binquan Zhou, Junhui Zhu, He Huang, Min Wang, G. Fu (2008)SDF-1alpha/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway.
Atherosclerosis, 201 1
M. Castellone, V. Guarino, V. Falco, F. Carlomagno, F. Basolo, P. Faviana, M. Kruhøffer, T. Orntoft, J. Russell, J. Rothstein, A. Fusco, M. Santoro, R. Melillo (2004)Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas
A. Orimo, Piyush Gupta, D. Sgroi, F. Arenzana‐Seisdedos, T. Delaunay, R. Naeem, V. Carey, A. Richardson, R. Weinberg (2005)Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
R. Arriagada, B. Bergman, A. Dunant, T. Chevalier, J. Pignon, J. Vansteenkiste (2004)Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
The New England journal of medicine, 350 4
R. Phillips, J. Mestas, M. Gharaee-Kermani, M. Burdick, A. Sica, J. Belperio, M. Keane, R. Strieter (2005)Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1α*
Journal of Biological Chemistry, 280
J. Spano, F. André, L. Morat, L. Sabatier, B. Besse, C. Combadière, P. Deterre, Anne-Laure Martin, J. Azorin, D. Valeyre, D. Khayat, T. Chevalier, J. Soria (2004)Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome.
Annals of oncology : official journal of the European Society for Medical Oncology, 15 4
John Liang, Shaobo Zhu, Richard Bruggeman, R. Zaino, Douglas Evans, J. Fleming, H. Gomez, D. Zander, Huamin Wang (2010)High Levels of Expression of Human Stromal Cell–Derived Factor-1 Are Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
Cancer Epidemiology, Biomarkers & Prevention, 19
P. Mehlen, A. Puisieux (2006)Metastasis: a question of life or death
Nature Reviews Cancer, 6
Zuo Tao (2012)Expression and Significance of CXCR4 Chemokine Receptor in Non Small Cell Lung Cancer
Chinese Journal of General Practice
R. Phillips, M. Burdick, M. Lutz, J. Belperio, M. Keane, R. Strieter (2003)The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.
American journal of respiratory and critical care medicine, 167 12
R. Phillips, J. Mestas, M. Gharaee-Kermani, M. Burdick, A. Sica, J. Belperio, M. Keane, R. Strieter (2005)Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.
The Journal of biological chemistry, 280 23
D. Vindrieux, P. Escobar, G. Lazennec (2009)Emerging roles of chemokines in prostate cancer.
Endocrine-related cancer, 16 3
Liping Su, Jin-ping Zhang, Huanbin Xu, Ying Wang, Y. Chu, Ruizi Liu, S. Xiong (2005)Differential Expression of CXCR4 Is Associated with the Metastatic Potential of Human Non–Small Cell Lung Cancer Cells
Clinical Cancer Research, 11
H. Broxmeyer, Christie Orschell, D. Clapp, G. Hangoc, S. Cooper, P. Plett, W. Liles, Xiaxin Li, B. Graham-Evans, Timothy Campbell, G. Calandra, G. Bridger, D. Dale, E. Srour (2005)Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
The Journal of Experimental Medicine, 201
L. Torregrossa, R. Giannini, N. Borrelli, E. Sensi, R. Melillo, P. Leocata, G. Materazzi, P. Miccoli, M. Santoro, F. Basolo (2012)CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas
Modern Pathology, 25
N. Dubrawsky (1989)Cancer statistics
CA: A Cancer Journal for Clinicians, 39
C. Rubie, V. Frick, P. Ghadjar, M. Wagner, C. Justinger, Sabrina Faust, Benjamin Vicinus, S. Gräber, O. Kollmar, M. Schilling (2011)CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells
Journal of Translational Medicine, 9
William Lee, Zhaoshi Jiang, Jinfeng Liu, Peter Haverty, Y. Guan, Jeremy Stinson, Peng Yue, Yan Zhang, K. Pant, Deepali Bhatt, Connie Ha, Stephanie Johnson, M. Kennemer, S. Mohan, Igor Nazarenko, C. Watanabe, A. Sparks, D. Shames, R. Gentleman, F. Sauvage, H. Stern, A. Pandita, D. Ballinger, R. Drmanac, Z. Modrušan, S. Seshagiri, Zemin Zhang (2010)The mutation spectrum revealed by paired genome sequences from a lung cancer patient
O. Wald, U. Izhar, G. Amir, S. Kirshberg, Zippora Shlomai, G. Zamir, A. Peled, O. Shapira (2011)Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferation.
The Journal of thoracic and cardiovascular surgery, 141 6
T. Gangadhar, S. Nandi, R. Salgia (2010)The role of chemokine receptor CXCR4 in lung cancer
Cancer Biology & Therapy, 9
Yi-Chia Huang, Yu-Chun Hsiao, Ying‐Ju Chen, Ying‐Ying Wei, Tzu-Hsu Lai, Chih-Hsin Tang (2007)Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-κB-dependent pathway in human lung cancer cells
Biochemical Pharmacology, 74
Yi-Chia Huang, Yu-Chun Hsiao, Ying‐Ju Chen, Ying‐Ying Wei, Tzu-Hsu Lai, Chih-Hsin Tang (2007)Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells.
Biochemical pharmacology, 74 12
Yanxi Sun, Jingcheng Wang, C. Shelburne, D. Lopatin, A. Chinnaiyan, M. Rubin, K. Pienta, R. Taichman (2003)Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo
Journal of Cellular Biochemistry, 89
F. Abedini, M. Ismail, H. Hosseinkhani, Tengku Azmi, Tengku Ibrahim, Abdul Omar, P. Chong, M. Bejo, A. DombCancer Management and Research Dovepress Effects of Cxcr4 Sirna/dextran-spermine Nanoparticles on Cxcr4 Expression and Serum Ldh Levels in a Mouse Model of Colorectal Cancer Metastasis to the Liver
A. Jemal, Taylor Murray, Elizabeth Ward, A. Samuels, R. Tiwari, Asma Ghafoor, E. Feuer, M. Thun (2005)Cancer Statistics, 2005
CA: A Cancer Journal for Clinicians, 55
P. Clapham, R. Weiss (1997)Immunodeficiency viruses: Spoilt for choice of co-receptors
Abedini (2011)Effects of CXCR4 siRNA/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver
Cancer Manag Res, 3
Soo-Jin Ok, Sung‐Moo Kim, Chulwon Kim, D. Nam, B. Shim, Sung-Hoon Kim, K. Ahn, Seung-hoon Choi, K. Ahn (2012)Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4
Immunopharmacology and Immunotoxicology, 34
A. Müller, B. Homey, H. Soto, Nianfeng Ge, D. Catron, Matthew Buchanan, T. Mcclanahan, E. Murphy, W. Yuan, S. Wagner, J. Barrera, A. Mohar, E. Verástegui, A. Zlotnik (2001)Involvement of chemokine receptors in breast cancer metastasis
Lung cancer ranks as the most common type of cancer in males worldwide. Although great advances have been achieved in chemotherapy and radiotherapy, the long‑term survival rate of lung cancer patients has not improved significantly. Dissemination of lung cancer in the thoracic cavity and metastatic spread to the liver, bone and brain are characteristic of non‑small cell lung cancer (NSCLC), constituting the primary source of morbidity and mortality in lung cancer. Increasing evidence also indicates that the CXC chemokine receptor 4 (CXCR4)/chemokine CXC motif ligand 12 (CXCL12) chemokine axis is important for the cell invasion and migration of lung cancer. CXCR4 is a G protein‑coupled receptor with a major role in lymphocyte homing. Its ligand, CXCL12, is secreted by target organs and functions as a highly efficient chemotactic factor for T cells, monocytes, pre‑B cells, dendritic cells and myeloid bone marrow‑derived cells. In the current study, recombinant CXCR4‑specific small interfering RNA‑pBSilence1.1 plasmids were constructed and transfected into the A549 NSCLC cell line in vitro. Reverse transcription polymerase chain reaction and western blotting revealed that CXCR4 was downregulated in transfected cells compared with control cells. The results of MTT and Transwell migration assays indicated that the specific downregulation of CXCR4 inhibited cell growth, invasiveness and migration. Thus, siRNA targeting of CXCR4 may effectively inhibit the effect of CXCL12/CXCR4 on increasing the metastatic potential of NSCLC.
Oncology Letters – Spandidos Publications
Published: Apr 1, 2014
Access the full text.
Sign up today, get DeepDyve free for 14 days.